Subscribe

Cardinal Health, Inc. (CAH)

USD233.66 -2.14 (-0.91%)
US NYSE S&P 500 Healthcare Medical - Distribution
Address 7000 Cardinal Place 43017
Dublin, OH, US
CEO Jason Hollar
IPO 1983-08-04
CIK 721371 ISIN US14149Y1082

Explore sections of this company profile

Also trades on London Stock Exchange · 0HTG.L (USD) New York Stock Exchange · CAH (USD)
Description

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

News Sentiment (7d)
79 Positive

5 articles

Market Cap & Enterprise Value
Merger & Acquisition History
Target company Ticker Date Filing
Sections 1995-10-10 View
Behrens 1996-03-25 View
Owen OWN 1997-02-12 View
MediQual 1997-07-08 View
Virtus LifeSci Biotech Clinical Trials ETF BBC 1998-01-21 View
Bergen 1998-06-12 View
Bergen Brunswig 1998-12-14 View
Bindley BDY 2001-01-08 View
Syncor 2002-10-16 View

Index membership

IndexAddedRemovedStatus
S&P 500 1997-05-23 Active
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD233.66 -2.14 (-0.91%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.49
Float Shares
234.72M
Free Float %
99.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.03% -4.72% -15.29% -15.11% -10.65% -11.16% +22.84% +115.36% +227.11% +137.09% +20,178.59%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (33 ratings, all time) Buy
Price Targets & DCF
Current price
233.66
Low 235.00 +0.6%
Consensus 253.38 +8.4%
Median 255.50 +9.3%
High 275.00 +17.7%
DCF (Unlevered) 374.35 +60.2%
DCF (Levered) 237.77 +1.8%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 83% Bullish
Rating 2026-05 Change
Strong Buy 3 0
Buy 12 0
Hold 3 -1
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month 1
248.00
+6.1%
Last Quarter 4
255.25
+9.2%
Last Year 25
229.04
-2.0%
All Time 53
160.92
-31.1%
Quality scores
Altman Z-Score
4.94
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Distribution: +5.6%
    -1.9% Q1'26: +11.0% (vs Q1'25)
  • EPS growth Medical - Distribution: +4.9%
    +87.0% Q1'26: -19.5% (vs Q1'25)
  • FCF margin FCF growth · Medical - Distribution: +37.6%
    +0.6% Q1'26: +2.8% (vs Q1'25)
  • EBIT margin Medical - Distribution: +3.0%
    +1.0% Q1'26: +0.8% (vs Q1'25)
  • ROIC Medical - Distribution: +5.7%
    +61.0% Q1'26: +85.6% (vs Q1'25)
  • Share dilution Medical - Distribution: +0.0%
    -2.0% Q1'26: -2.1% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Distribution: 0.87×
    3.01× Q1'26: 2.94× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.54) × ERP
WACC = 83% × Ke + 17% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 369.59 Current price: 233.66
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Jun 2011
actual
Jun 2012
actual
Jun 2013
actual
Jun 2014
actual
Jun 2015
actual
Jun 2016
actual
Jun 2017
actual
Jun 2018
actual
Jun 2019
actual
Jun 2020
actual
Jun 2021
actual
Jun 2022
actual
Jun 2023
actual
Jun 2024
actual
Jun 2025
actual
Jun 2026
12 Rev. Ana.
10 EPS Ana.
Jun 2027
12 Rev. Ana.
11 EPS Ana.
Jun 2028
12 Rev. Ana.
5 EPS Ana.
Jun 2029
10 Rev. Ana.
1 EPS Ana.
Jun 2030
6 Rev. Ana.
1 EPS Ana.
Revenue
102.64B
est: 87.54B (+17.2%)
107.55B
est: 99.91B (+7.6%)
101.09B
est: 100.18B (+0.9%)
91.08B
est: 91.32B (-0.3%)
102.53B
est: 100.98B (+1.5%)
121.55B
est: 121.28B (+0.2%)
129.98B
est: 129.70B (+0.2%)
136.81B
est: 135.79B (+0.7%)
145.53B
est: 144.88B (+0.5%)
152.92B
est: 153.20B (-0.2%)
162.47B
est: 160.21B (+1.4%)
181.33B
est: 178.77B (+1.4%)
204.98B
est: 204.30B (+0.3%)
226.83B
est: 225.71B (+0.5%)
222.58B
est: 223.26B (-0.3%)
256.05B
254.62B – 257.99B
+14.7% YoY
277.11B
271.88B – 282.42B
+8.2% YoY
299.22B
298.77B – 299.67B
+8.0% YoY
322.74B
316.72B – 327.65B
+7.9% YoY
339.07B
332.74B – 344.23B
+5.1% YoY
EBITDA
1.92B
est: 1.54B (+24.6%)
2.12B
est: 1.81B (+16.7%)
1.41B
est: 2.15B (-34.4%)
2.39B
est: 1.37B (+74.4%)
2.56B
est: 2.24B (+14.2%)
3.10B
est: 2.63B (+17.7%)
2.84B
est: 2.87B (-1.0%)
1.13B
est: 2.27B (-50.1%)
3.05B
est: 1.54B (+97.7%)
-2.62B
est: -2.77B (+5.3%)
1.29B
est: 1.86B (-31.0%)
55.00M
est: 997.53M (-94.5%)
1.44B
est: 421.53M (+241.4%)
1.96B
est: 5.43B (-63.9%)
3.11B
est: 5.37B (-42.2%)
6.16B
6.13B – 6.21B
+14.7% YoY
6.67B
6.54B – 6.79B
+8.2% YoY
7.20B
7.19B – 7.21B
+8.0% YoY
7.76B
7.62B – 7.88B
+7.9% YoY
8.16B
8.00B – 8.28B
+5.1% YoY
EBIT
1.61B
est: 1.22B (+32.2%)
1.79B
est: 1.54B (+16.3%)
1.01B
est: 1.80B (-43.8%)
1.93B
est: 928.57M (+108.0%)
2.11B
est: 1.83B (+15.3%)
2.45B
est: 2.14B (+14.9%)
2.13B
est: 2.24B (-5.0%)
101.00M
est: 1.50B (-93.3%)
2.05B
est: 671.15M (+204.7%)
-3.53B
est: -3.57B (+0.9%)
503.00M
est: 672.91M (-25.3%)
-637.00M
est: 202.72M (-414.2%)
747.00M
est: -406.10M (+283.9%)
1.25B
est: 4.99B (-74.9%)
2.32B
est: 4.93B (-53.0%)
5.66B
5.63B – 5.70B
+14.7% YoY
6.12B
6.01B – 6.24B
+8.2% YoY
6.61B
6.60B – 6.62B
+8.0% YoY
7.13B
7.00B – 7.24B
+7.9% YoY
7.49B
7.35B – 7.60B
+5.1% YoY
Net Income
959.00M
est: 821.25M (+16.8%)
1.07B
est: 877.20M (+21.9%)
334.00M
est: 1.09B (-69.3%)
1.17B
est: 322.29M (+261.8%)
1.22B
est: 1.06B (+14.5%)
1.43B
est: 1.25B (+14.3%)
1.29B
est: 1.28B (+0.4%)
256.00M
est: 1.45B (-82.3%)
1.36B
est: -84.12M (+1,720.4%)
-3.69B
est: -3.58B (-3.3%)
611.00M
est: 1.20B (-49.3%)
-938.00M
est: 601.41M (-256.0%)
330.00M
est: 156.00M (+111.5%)
852.00M
est: 1.78B (-52.1%)
1.56B
est: 1.98B (-21.1%)
2.57B
2.52B – 2.63B
+30.0% YoY
2.89B
2.82B – 2.97B
+12.5% YoY
3.14B
2.47B – 3.82B
+8.7% YoY
3.64B
3.55B – 3.71B
+15.6% YoY
4.34B
4.23B – 4.42B
+19.3% YoY
SGA
2.59B
est: 2.14B (+21.4%)
2.68B
est: 2.46B (+8.8%)
2.88B
est: 2.65B (+8.4%)
3.03B
est: 2.81B (+7.9%)
3.24B
est: 2.99B (+8.2%)
3.65B
est: 3.14B (+16.1%)
3.78B
est: 3.53B (+6.9%)
4.60B
est: 3.58B (+28.2%)
4.48B
est: 4.18B (+7.1%)
4.57B
est: 3.73B (+22.7%)
4.53B
est: 3.66B (+23.8%)
4.51B
est: 4.91B (-8.1%)
4.80B
est: 5.35B (-10.2%)
5.00B
est: 5.53B (-9.5%)
5.38B
est: 5.47B (-1.5%)
6.27B
6.23B – 6.32B
+14.7% YoY
6.79B
6.66B – 6.92B
+8.2% YoY
7.33B
7.32B – 7.34B
+8.0% YoY
7.90B
7.75B – 8.02B
+7.9% YoY
8.30B
8.15B – 8.43B
+5.1% YoY
EPS
2.75
est: 1.90 (+44.7%)
3.10
est: 2.55 (+21.6%)
0.98
est: 3.09 (-68.3%)
3.42
est: 3.21 (+6.5%)
3.66
est: 4.37 (-16.2%)
4.36
est: 5.23 (-16.7%)
4.06
est: 5.35 (-24.1%)
0.82
est: 4.93 (-83.4%)
4.54
est: 5.10 (-11.0%)
-12.60
est: 5.30 (-337.6%)
2.09
est: 5.99 (-65.1%)
-3.34
est: 5.19 (-164.4%)
1.26
est: 5.74 (-78.1%)
3.48
est: 7.36 (-52.7%)
6.48
est: 8.20 (-20.9%)
10.74
10.40 – 10.85
+31.1% YoY
11.99
11.64 – 12.26
+11.6% YoY
13.52
10.19 – 15.80
+12.8% YoY
15.02
14.66 – 15.32
+11.1% YoY
17.92
17.49 – 18.27
+19.3% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-05-04 JP Morgan Neutral Neutral Maintain
2026-05-01 Wells Fargo Overweight Overweight Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-05-08 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-05-07 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-05-06 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-05-05 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-05-04 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-05-01 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-04-30 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-04-29 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-04-28 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-04-27 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-04-24 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-04-23 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-04-22 C+ 2/5 4/5 1/5 4/5 1/5 2/5 1/5
2026-04-21 B- 2/5 4/5 1/5 5/5 1/5 2/5 1/5
2026-04-20 B- 2/5 4/5 1/5 5/5 1/5 2/5 1/5
2026-04-17 B- 2/5 4/5 1/5 5/5 1/5 2/5 1/5
2026-04-16 B- 2/5 4/5 1/5 5/5 1/5 2/5 1/5
2026-04-15 B- 2/5 4/5 1/5 5/5 1/5 2/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
4.77B
OE per share TTM
20.05
Owner's Yield
11.12%
Maintenance CapEx ratio
16.33%
Maint CapEx / Avg PPE
1.3%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
554
Total invested
2.88B
Insider transactions (90d)
0
Beneficial owners (>5%)
19
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 The Vanguard Group - 23-1945930 35.84M 12.72% 471.1K 34.65M 1.19M IA Pennsylvania 2022-02-09
2 Wellington Management Company, LLP 34.74M 10.21% 9.34M IA Massachusetts 2014-07-10
3 04-2683227 32.99M 9.66% 8.00M IA Massachusetts 2014-02-14
4 (1) BlackRock, Inc. 28.95M 10.60% 26.07M 28.95M HC Delaware 2022-09-08
5 STATE STREET CORPORATION 21.38M 7.59% 19.46M 21.35M HC 2022-02-10
6 752403190 17.88M 5.68% 4.57M 13.30M 17.88M IA A Delaware limited liability company 2018-02-12
7 Wellington Management Company LLP 17.81M 5.73% 4.23M IA Delaware 2018-08-10
8 52-0556948 15.03M 5.30% 5.98M 15.03M IA Maryland 2022-02-14
9 Macquarie Bank Limited 12.14M 4.13% CO 2021-02-12
10 Macquarie Group Limited 12.14M 4.13% HC 2021-02-12
11 Macquarie Investment Management Business Trust 12.05M 4.11% 11.66M 11.66M IA 2021-02-12
12 Macquarie Investment Management Holdings Inc 12.05M 4.11% 11.66M 11.66M HC 2021-02-12
13 Cardinal Health, Inc. 10.00M 5.80% 10.00M 10.00M CO Ohio 2017-03-13
14 Wellington Group Holdings LLP 9.06M 3.04% 1.48M HC Delaware 2019-02-12
15 Wellington Investment Advisors Holdings LLP 9.06M 3.04% 1.48M HC Delaware 2019-02-12
16 Wellington Management Group LLP 9.06M 3.04% 1.48M HC Massachusetts 2019-02-12
17 Macquarie Investment Management Australia Limited 82.1K 0.02% 82.1K 82.1K CO 2021-02-12
18 Macquarie Investment Management Austria Kapitalanlage AG 13.7K 0.00% 13.7K 13.7K CO Vienna, Austria 2020-02-13
19 Macquarie Capital (USA) Inc. 6.7K 0.00% 6.7K 6.7K CO Sydney, New South Wales, Australia 2020-02-13

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
554
-885 vs prev Q
New positions
57
Closed positions
899
Increased
251
Reduced
201
Put/Call ratio
0.00
Calls held
Puts held
2.5K
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 VANGUARD GROUP INC 31.44M +617.8K (+2.0%) 6.46B +1.6B (+33.5%) 13.32% +0.426 pp 0.09% +0.021 pp USD75.73 +171.4% 84 qtrs
2 BLACKROCK, INC. 28.64M -2.8M (-9.0%) 5.89B +947.2M (+19.2%) 12.14% -1.029 pp 0.10% +0.013 pp USD111.92 +83.6% 6 qtrs
3 STATE STREET CORP 12.51M +221.5K (+1.8%) 2.57B +642.0M (+33.3%) 5.30% +0.159 pp 0.09% +0.019 pp USD57.31 +258.6% 51 qtrs
4 GEODE CAPITAL MANAGEMENT, LLC 6.53M +43.9K (+0.7%) 1.34B +322.8M (+31.8%) 2.77% +0.053 pp 0.08% +0.018 pp USD68.90 +198.3% 78 qtrs
5 WELLINGTON MANAGEMENT GROUP LLP 5.17M -637.4K (-11.0%) 1.06B +150.7M (+16.5%) 2.19% -0.239 pp 0.19% +0.027 pp USD148.89 +38.0% 81 qtrs
6 MORGAN STANLEY 5.12M -107.6K (-2.1%) 1.05B +231.8M (+28.2%) 2.17% -0.018 pp 0.06% +0.013 pp USD75.67 +171.6% 51 qtrs
7 FMR LLC 4.60M -819.0K (-15.1%) 945.52M +94.8M (+11.1%) 1.95% -0.318 pp 0.05% +0.004 pp USD103.19 +99.1% 70 qtrs
8 WCM INVESTMENT MANAGEMENT, LLC 4.03M +4.0M (+100.0%) 835.61M +835.6M (+100.0%) 1.71% +1.709 pp 1.72% +1.721 pp USD205.50 +0.0% 1 qtrs NEW
9 NORGES BANK 3.85M +3.8M (+100.0%) 790.34M +790.3M (+100.0%) 1.63% +1.630 pp 0.08% +0.085 pp USD205.50 +0.0% 1 qtrs NEW
10 BANK OF AMERICA CORP /DE/ 3.29M -304.0K (-8.5%) 675.83M +111.9M (+19.8%) 1.39% -0.110 pp 0.05% +0.011 pp USD98.44 +108.8% 52 qtrs
11 NORTHERN TRUST CORP 2.86M -70.8K (-2.4%) 586.77M +127.5M (+27.8%) 1.21% -0.014 pp 0.07% +0.016 pp USD66.01 +211.3% 51 qtrs
12 VICTORY CAPITAL MANAGEMENT INC 2.70M +414.1K (+18.1%) 554.48M +202.3M (+57.4%) 1.14% +0.188 pp 0.31% +0.107 pp USD142.35 +44.4% 44 qtrs
13 JPMORGAN CHASE & CO 2.63M -267.9K (-9.2%) 540.63M +85.6M (+18.8%) 1.11% -0.098 pp 0.03% +0.007 pp USD111.17 +84.9% 51 qtrs
14 INVESCO LTD. 2.58M -898.5K (-25.8%) 531.16M -15.6M (-2.8%) 1.10% -0.362 pp 0.08% -0.005 pp USD83.27 +146.8% 57 qtrs
15 UBS ASSET MANAGEMENT AMERICAS INC 2.31M -201.2K (-8.0%) 475.49M +80.7M (+20.5%) 0.98% -0.072 pp 0.10% +0.015 pp USD83.24 +146.9% 90 qtrs
16 LEGAL & GENERAL GROUP PLC 2.13M -12.1K (-0.6%) 436.98M +101.3M (+30.2%) 0.90% +0.006 pp 0.10% +0.022 pp USD59.86 +243.3% 75 qtrs
17 GOLDMAN SACHS GROUP INC 2.05M +74.1K (+3.7%) 421.63M +111.2M (+35.8%) 0.87% +0.042 pp 0.05% +0.014 pp USD109.22 +88.2% 73 qtrs
18 CITADEL ADVISORS LLC 1.88M +934.8K (+99.2%) 385.66M +237.8M (+160.8%) 0.80% +0.401 pp 0.06% +0.035 pp USD158.19 +29.9% 52 qtrs
19 PRICE T ROWE ASSOCIATES INC /MD/ 1.87M -101.4K (-5.2%) 383.52M +74.7M (+24.2%) 0.79% -0.033 pp 0.04% +0.008 pp USD78.64 +161.3% 75 qtrs
20 BNP PARIBAS ARBITRAGE, SNC 1.59M -368.4K (-18.8%) 326.40M +19.3M (+6.3%) 0.67% -0.146 pp 0.15% -0.016 pp USD124.82 +64.6% 51 qtrs
21 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.56M +5.2K (+0.3%) 320.08M +76.4M (+31.4%) 0.66% +0.011 pp 0.05% +0.011 pp USD62.67 +227.9% 100 qtrs
22 VOYA INVESTMENT MANAGEMENT LLC 1.44M +614.9K (+74.8%) 295.23M +166.2M (+128.9%) 0.61% +0.265 pp 0.29% +0.162 pp USD164.79 +24.7% 51 qtrs
23 ACADIAN ASSET MANAGEMENT LLC 1.43M +400.7K (+38.9%) 293.86M +132.3M (+81.9%) 0.61% +0.175 pp 0.48% +0.201 pp USD149.72 +37.3% 50 qtrs
24 BANK OF NEW YORK MELLON CORP 1.39M -47.1K (-3.3%) 286.43M +60.3M (+26.6%) 0.59% -0.012 pp 0.05% +0.007 pp USD53.99 +280.6% 66 qtrs
25 AQR CAPITAL MANAGEMENT LLC 1.35M +25.3K (+1.9%) 278.20M +71.3M (+34.5%) 0.57% +0.018 pp 0.15% +0.013 pp USD87.27 +135.5% 92 qtrs
26 PACER ADVISORS, INC. 1.30M +444.0K (+52.0%) 266.56M +132.6M (+99.1%) 0.55% +0.193 pp 0.68% +0.344 pp USD179.98 +14.2% 44 qtrs
27 BARCLAYS PLC 1.21M +501.2K (+70.8%) 248.37M +170.2M (+217.7%) 0.51% +0.216 pp 0.06% +0.040 pp USD141.95 +44.8% 51 qtrs
28 DIMENSIONAL FUND ADVISORS LP 1.18M -71.2K (-5.7%) 241.54M +45.9M (+23.5%) 0.50% -0.024 pp 0.05% +0.009 pp USD57.62 +256.6% 51 qtrs
29 QUBE RESEARCH & TECHNOLOGIES LTD 1.05M -326.9K (-23.8%) 215.19M -489.8K (-0.2%) 0.44% -0.131 pp 0.22% -0.004 pp USD103.08 +99.4% 13 qtrs
30 PROSHARE ADVISORS LLC 1.04M -66.4K (-6.0%) 214.14M +40.2M (+23.1%) 0.44% -0.022 pp 0.38% +0.014 pp USD62.28 +230.0% 77 qtrs
31 KBC GROUP NV 1.02M +5.6K (+0.6%) 210.01M +50.5M (+31.6%) 0.43% +0.008 pp 0.48% +0.096 pp USD105.13 +95.5% 68 qtrs
32 MAN GROUP PLC 1.02M -584.6K (-36.4%) 209.77M -42.2M (-16.7%) 0.43% -0.239 pp 0.36% -0.082 pp USD113.17 +81.6% 32 qtrs
33 DEUTSCHE BANK AG\ 993.2K +6.8K (+0.7%) 204.11M +49.3M (+31.8%) 0.42% +0.008 pp 0.07% +0.015 pp USD88.77 +131.5% 50 qtrs
34 HOLOCENE ADVISORS, LP 989.5K -936.7K (-48.6%) 203.34M -99.0M (-32.7%) 0.42% -0.387 pp 0.43% -0.262 pp USD147.90 +38.9% 11 qtrs
35 UBS GROUP AG 968.8K -35.5K (-3.5%) 199.10M +41.5M (+26.3%) 0.41% -0.010 pp 0.03% +0.008 pp USD97.62 +110.5% 45 qtrs
36 MARSHALL WACE, LLP 951.3K +884.6K (+1,328.1%) 195.48M +185.0M (+1,769.7%) 0.40% +0.375 pp 0.18% +0.167 pp USD199.77 +2.9% 31 qtrs
37 NUVEEN, LLC 944.9K +21.8K (+2.4%) 194.17M +49.3M (+34.0%) 0.40% +0.014 pp 0.05% +0.013 pp USD142.78 +43.9% 4 qtrs
38 ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. 891.3K -45.5K (-4.9%) 183.16M +36.1M (+24.6%) 0.38% -0.014 pp 0.26% +0.048 pp USD78.81 +160.8% 68 qtrs
39 ENVESTNET ASSET MANAGEMENT INC 883.4K +132.7K (+17.7%) 181.53M +63.7M (+54.1%) 0.37% +0.060 pp 0.05% +0.020 pp USD106.90 +92.2% 51 qtrs
40 AMERIPRISE FINANCIAL INC 818.6K -636.6K (-43.7%) 168.22M -60.3M (-26.4%) 0.35% -0.262 pp 0.04% -0.015 pp USD101.87 +101.7% 56 qtrs
41 TWO SIGMA INVESTMENTS, LP 805.8K +652.4K (+425.2%) 165.59M +141.5M (+587.6%) 0.34% +0.277 pp 0.23% +0.198 pp USD186.31 +10.3% 18 qtrs
42 BRANDES INVESTMENT PARTNERS, LP 781.9K -208.7K (-21.1%) 160.68M +5.2M (+3.3%) 0.33% -0.083 pp 1.22% -0.024 pp USD68.22 +201.2% 35 qtrs
43 RENAISSANCE TECHNOLOGIES LLC 773.8K +81.5K (+11.8%) 159.02M +50.4M (+46.3%) 0.33% +0.038 pp 0.25% +0.103 pp USD112.03 +83.4% 33 qtrs
44 AUSTRALIANSUPER PTY LTD 765.0K +84.8K (+12.5%) 157.21M +50.5M (+47.3%) 0.32% +0.040 pp 0.73% +0.240 pp USD165.25 +24.4% 3 qtrs
45 FEDERATED HERMES, INC. 763.6K -197.3K (-20.5%) 156.91M +6.1M (+4.0%) 0.32% -0.079 pp 0.26% -0.004 pp USD122.22 +68.1% 54 qtrs
46 AMUNDI 736.4K +55.8K (+8.2%) 151.34M +45.7M (+43.3%) 0.31% +0.027 pp 0.04% +0.007 pp USD72.74 +182.5% 19 qtrs
47 SG AMERICAS SECURITIES, LLC 727.5K +709.0K (+3,829.1%) 149.50M +146.6M (+5,044.7%) 0.31% +0.301 pp 0.19% +0.181 pp USD203.39 +1.0% 51 qtrs
48 WELLS FARGO & COMPANY/MN 722.4K -9.9K (-1.4%) 148.46M +33.5M (+29.1%) 0.31% 0.000 pp 0.03% +0.005 pp USD85.07 +141.6% 57 qtrs
49 PRUDENTIAL FINANCIAL INC 710.1K +496.3K (+232.1%) 145.92M +112.4M (+334.9%) 0.30% +0.211 pp 0.18% +0.136 pp USD190.18 +8.1% 85 qtrs
50 ROYAL BANK OF CANADA 707.3K +113.6K (+19.1%) 145.35M +52.2M (+56.0%) 0.30% +0.051 pp 0.02% +0.008 pp USD112.68 +82.4% 51 qtrs
51 BANK OF NOVA SCOTIA 692.6K +299.1K (+76.0%) 142.33M +80.6M (+130.5%) 0.29% +0.129 pp 0.21% +0.102 pp USD168.25 +22.1% 52 qtrs
52 SEI INVESTMENTS CO 686.4K +198.7K (+40.7%) 141.05M +64.5M (+84.3%) 0.29% +0.087 pp 0.14% +0.057 pp USD123.03 +67.0% 45 qtrs
53 VOLORIDGE INVESTMENT MANAGEMENT, LLC 651.9K -115.8K (-15.1%) 133.96M +13.5M (+11.2%) 0.28% -0.045 pp 0.47% +0.066 pp USD106.66 +92.7% 26 qtrs
54 NORDEA INVESTMENT MANAGEMENT AB 645.4K +494.7K (+328.3%) 133.74M +110.2M (+467.5%) 0.27% +0.210 pp 0.11% +0.094 pp USD192.69 +6.6% 88 qtrs
55 SWISS NATIONAL BANK 650.4K -37.6K (-5.5%) 133.66M +25.7M (+23.8%) 0.28% -0.012 pp 0.08% +0.017 pp USD73.42 +179.9% 51 qtrs
56 CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 644.6K -146.7K (-18.5%) 132.46M +8.3M (+6.7%) 0.27% -0.058 pp 0.08% +0.001 pp USD82.12 +150.2% 58 qtrs
57 SCHRODER INVESTMENT MANAGEMENT GROUP 614.4K +52.7K (+9.4%) 127.30M +40.5M (+46.6%) 0.26% +0.025 pp 0.10% +0.030 pp USD157.90 +30.1% 51 qtrs
58 HSBC HOLDINGS PLC 612.5K -103.1K (-14.4%) 126.04M +13.6M (+12.1%) 0.26% -0.040 pp 0.06% +0.002 pp USD116.48 +76.4% 56 qtrs
59 RHUMBLINE ADVISERS 606.6K -12.6K (-2.0%) 124.65M +27.5M (+28.3%) 0.26% -0.002 pp 0.10% +0.023 pp USD68.35 +200.7% 52 qtrs
60 SUMITOMO MITSUI TRUST HOLDINGS, INC. 603.6K -26.1K (-4.2%) 124.03M +25.2M (+25.5%) 0.26% -0.008 pp 0.07% +0.016 pp USD53.45 +284.5% 59 qtrs
61 FRANKLIN RESOURCES INC 585.1K +98.0K (+20.1%) 120.23M +43.8M (+57.3%) 0.25% +0.044 pp 0.03% +0.010 pp USD159.06 +29.2% 51 qtrs
62 RAYMOND JAMES FINANCIAL INC 577.5K +44.1K (+8.3%) 118.82M +35.1M (+41.9%) 0.24% +0.022 pp 0.04% +0.010 pp USD132.00 +55.7% 5 qtrs
63 FARALLON CAPITAL MANAGEMENT LLC 576.0K +323.0K (+127.7%) 118.37M +78.7M (+198.1%) 0.24% +0.138 pp 0.56% +0.396 pp USD181.04 +13.5% 4 qtrs
64 POINT72 ASSET MANAGEMENT, L.P. 548.3K +424.3K (+342.2%) 112.68M +93.2M (+478.9%) 0.23% +0.180 pp 0.13% +0.093 pp USD184.51 +11.4% 7 qtrs
65 MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 529.9K +25.3K (+5.0%) 109.00M +29.8M (+37.6%) 0.22% +0.013 pp 0.07% +0.017 pp USD89.02 +130.8% 58 qtrs
66 SQUAREPOINT OPS LLC 530.1K -578.3K (-52.2%) 108.95M -65.0M (-37.4%) 0.22% -0.239 pp 0.12% -0.059 pp USD149.05 +37.9% 35 qtrs
67 NATIXIS ADVISORS, L.P. 521.3K +85.6K (+19.6%) 107.12M +38.7M (+56.6%) 0.22% +0.039 pp 0.15% +0.052 pp USD106.59 +92.8% 57 qtrs
68 D. E. SHAW & CO., INC. 489.6K -122.4K (-20.0%) 100.62M +4.6M (+4.7%) 0.21% -0.049 pp 0.06% +0.001 pp USD113.94 +80.4% 76 qtrs
69 NATIONAL PENSION SERVICE 485.0K -15.3K (-3.1%) 99.67M +21.1M (+26.9%) 0.21% -0.004 pp 0.07% +0.013 pp USD66.28 +210.0% 46 qtrs
70 CAPITAL INTERNATIONAL INVESTORS 472.4K +472.4K (+100.0%) 97.08M +97.1M (+100.0%) 0.20% +0.200 pp 0.02% +0.015 pp USD205.50 +0.0% 1 qtrs NEW
71 TWO SIGMA ADVISERS, LP 469.3K +453.7K (+2,908.3%) 96.44M +94.0M (+3,838.7%) 0.20% +0.192 pp 0.19% +0.183 pp USD202.06 +1.7% 50 qtrs
72 JANE STREET GROUP, LLC 452.2K +437.5K (+2,983.4%) 92.92M +90.6M (+3,936.9%) 0.19% +0.186 pp 0.01% +0.014 pp USD202.27 +1.6% 48 qtrs
73 SUSQUEHANNA INTERNATIONAL GROUP, LLP 450.6K +13.1K (+3.0%) 92.60M +23.9M (+34.8%) 0.19% +0.008 pp 0.01% +0.003 pp USD123.85 +65.9% 51 qtrs
74 NATIONAL BANK OF CANADA /FI/ 433.8K +95.9K (+28.4%) 89.14M +36.1M (+68.1%) 0.18% +0.042 pp 0.08% +0.028 pp USD142.71 +44.0% 17 qtrs
75 CIBC PRIVATE WEALTH GROUP, LLC 431.8K -10.0K (-2.3%) 88.73M +19.4M (+28.0%) 0.18% -0.002 pp 0.15% +0.031 pp USD99.63 +106.3% 40 qtrs
76 ING GROEP NV 430.2K -87.9K (-17.0%) 88.41M +7.1M (+8.7%) 0.18% -0.035 pp 0.53% +0.093 pp USD153.68 +33.7% 51 qtrs
77 LPL FINANCIAL LLC 424.7K +1.0K (+0.2%) 87.28M +20.8M (+31.2%) 0.18% +0.003 pp 0.02% +0.005 pp USD117.45 +75.0% 51 qtrs
78 SWEDBANK AB 415.7K -12.8K (-3.0%) 85.43M +18.2M (+27.0%) 0.18% -0.003 pp 0.08% +0.015 pp USD60.14 +241.7% 20 qtrs
79 RUSSELL INVESTMENTS GROUP, LTD. 408.8K -86.4K (-17.4%) 84.13M +6.5M (+8.4%) 0.17% -0.034 pp 0.09% +0.004 pp USD83.44 +146.3% 37 qtrs
80 SILVERCREST ASSET MANAGEMENT GROUP LLC 408.7K -14.1K (-3.3%) 83.99M +17.6M (+26.6%) 0.17% -0.004 pp 0.58% +0.138 pp USD163.00 +26.1% 60 qtrs
81 FRED ALGER MANAGEMENT, LLC 404.7K -68.0K (-14.4%) 83.16M +9.0M (+12.1%) 0.17% -0.026 pp 0.33% +0.037 pp USD155.95 +31.8% 14 qtrs
82 MILLENNIUM MANAGEMENT LLC 404.4K -1.6M (-79.6%) 83.11M -228.4M (-73.3%) 0.17% -0.659 pp 0.03% -0.098 pp USD126.77 +62.1% 34 qtrs
83 CITIGROUP INC 395.8K -5.9K (-1.5%) 81.34M +18.3M (+29.0%) 0.17% 0.000 pp 0.04% +0.008 pp USD98.55 +108.5% 108 qtrs
84 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 380.4K -39.1K (-9.3%) 78.18M +12.3M (+18.7%) 0.16% -0.014 pp 0.08% +0.011 pp USD54.88 +274.5% 52 qtrs
85 RETIREMENT SYSTEMS OF ALABAMA 377.9K -395.0 (-0.1%) 77.66M +18.3M (+30.8%) 0.16% +0.002 pp 0.25% +0.055 pp USD56.72 +262.3% 52 qtrs
86 TD ASSET MANAGEMENT INC 374.5K +22.0K (+6.3%) 76.97M +21.6M (+39.1%) 0.16% +0.011 pp 0.06% +0.017 pp USD89.76 +128.9% 51 qtrs
87 ARTEMIS INVESTMENT MANAGEMENT LLP 344.2K +50.5K (+17.2%) 70.74M +24.6M (+53.4%) 0.15% +0.023 pp 0.85% +0.281 pp USD160.88 +27.7% 4 qtrs
88 DELTA ACCUMULATION, LLC 336.8K +153.7K (+83.9%) 69.21M +49.0M (+242.0%) 0.14% +0.066 pp 2.55% +1.284 pp USD180.37 +13.9% 12 qtrs
89 WOODLINE PARTNERS LP 328.3K +328.3K (+100.0%) 67.47M +67.5M (+100.0%) 0.14% +0.139 pp 0.26% +0.261 pp USD205.50 +0.0% 5 qtrs
90 NEW YORK STATE COMMON RETIREMENT FUND 327.1K +— (+0.0%) 67.23M +15.9M (+30.9%) 0.14% +0.002 pp 0.09% +0.023 pp USD53.47 +284.3% 103 qtrs
91 COLONY GROUP, LLC 328.4K -40.6K (-11.0%) 67.22M +26.0M (+63.2%) 0.14% -0.015 pp 0.08% +0.010 pp USD154.75 +32.8% 9 qtrs
92 CBOE VEST FINANCIAL, LLC 319.7K -45.7K (-12.5%) 65.70M +8.3M (+14.5%) 0.14% -0.017 pp 0.83% +0.084 pp USD88.87 +131.2% 21 qtrs
93 NOMURA ASSET MANAGEMENT CO LTD 315.9K -25.0K (-7.3%) 64.91M +11.4M (+21.3%) 0.13% -0.009 pp 0.16% +0.025 pp USD72.89 +181.9% 76 qtrs
94 DEKABANK DEUTSCHE GIROZENTRALE 570.5K +— (+0.0%) 64.40M -23.6M (-26.8%) 0.24% +0.003 pp 0.11% -0.037 pp USD85.25 +141.1% 65 qtrs
95 ALLIANCEBERNSTEIN L.P. 311.6K +32.0K (+11.4%) 64.04M +20.2M (+45.9%) 0.13% +0.015 pp 0.02% +0.006 pp USD81.41 +152.4% 61 qtrs
96 ZURICH INSURANCE GROUP LTD/FI 295.3K +276.5K (+1,470.6%) 60.68M +57.7M (+1,956.3%) 0.13% +0.117 pp 0.42% +0.400 pp USD201.14 +2.2% 15 qtrs
97 PRINCIPAL FINANCIAL GROUP INC 287.5K +11.1K (+4.0%) 59.09M +15.7M (+36.2%) 0.12% +0.006 pp 0.03% +0.008 pp USD69.13 +197.3% 81 qtrs
98 ZACKS INVESTMENT MANAGEMENT 286.3K +9.9K (+3.6%) 58.83M +15.5M (+35.6%) 0.12% +0.006 pp 0.46% +0.117 pp USD135.02 +52.2% 9 qtrs
99 268.1K +268.1K (+100.0%) 55.56M +55.6M (+100.0%) 0.11% +0.114 pp 0.16% +0.158 pp USD205.50 +0.0% 1 qtrs NEW
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
381.00
Shares disposed
Cash buys
Cash sales
Net activity
+381
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-04-15 Hall Patricia Hemingway Director A-Award A Common Shares 381 207.83 79.2K 28,645 D
2026-02-27 Greene Michelle D. Officer S-Sale D Common Shares 100 228.55 22.9K 14,876 D
2026-02-18 Alt Aaron E Officer S-Sale D Common Shares 2,328 225.50 525.0K 26,408 D
2026-02-15 Alt Aaron E Officer F-InKind D Common Shares 1,914 220.79 422.6K 28,736 D
2026-02-06 Hall Patricia Hemingway Director S-Sale D Common Shares 4,000 229.72 918.9K 28,264 D
2026-01-15 Pitteroff Valerie Christine Officer A-Award A Common Shares 3,982 213.26 849.2K 8,022 D
2025-12-29 Pitteroff Valerie Christine Officer Common Shares 0 0.00 4,040 D
2025-12-01 WEITZMAN DEBORAH Officer F-InKind D Common Shares 551 212.26 117.0K 52,877 D
2025-12-01 Snow Ola M Officer F-InKind D Common Shares 320 212.26 67.9K 15,111 D
2025-12-01 Scherer Mary C. Officer F-InKind D Common Shares 61 212.26 12.9K 3,495 D
2025-12-01 Mayer Jessica L Officer F-InKind D Common Shares 422 212.26 89.6K 34,427 D
2025-12-01 Mason Stephen M Officer F-InKind D Common Shares 595 212.26 126.3K 25,490 D
2025-11-05 Ramakrishna Sudhakar Director A-Award A Common Shares 1,067 0.00 2,116 D
2025-11-05 Musslewhite Robert W Director A-Award A Common Shares 1,067 0.00 2,116 D
2025-11-05 MUNDKUR CHRISTINE Director A-Award A Common Shares 1,067 0.00 7,536 D
2025-11-05 Killefer Nancy Director A-Award A Common Shares 1,067 0.00 27,624 D
2025-11-05 KENNY GREGORY B Director A-Award A Common Shares 1,702 0.00 64,194 D
2025-11-05 JOHRI AKHIL Director A-Award A Common Shares 1,067 0.00 22,868 D
2025-11-05 Hall Patricia Hemingway Director A-Award A Common Shares 1,067 0.00 32,264 D
2025-11-05 Evans David C Director A-Award A Common Shares 1,067 0.00 15,373 D
2025-11-05 Edison Sheri H. Director A-Award A Common Shares 1,067 0.00 14,848 D
2025-11-05 Brennan Michelle Director A-Award A Common Shares 1,067 0.00 8,086 D
2025-11-05 Azelby Robert Director A-Award A Common Shares 1,067 0.00 4,085 D
2025-08-20 WEITZMAN DEBORAH Officer S-Sale D Common Shares 21,367 150.53 3.22M 53,428 D
2025-08-20 Hollar Jason M. Officer S-Sale D Common Shares 12,944 149.40 1.93M 222,957 D
2025-08-19 Snow Ola M Officer S-Sale D Common Shares 23,700 148.86 3.53M 19,882 D
2025-08-19 Scherer Mary C. Officer S-Sale D Common Shares 6,766 149.25 1.01M 3,556 D
2025-08-19 Mayer Jessica L Officer S-Sale D Common Shares 33,333 148.91 4.96M 48,857 D
2025-08-19 Mason Stephen M Officer S-Sale D Common Shares 4,167 149.39 622.5K 26,085 D
2025-08-19 Hollar Jason M. Officer S-Sale D Common Shares 94,735 148.92 14.11M 242,214 D
2025-08-19 Greene Michelle D. Officer S-Sale D Common Shares 11,994 148.76 1.78M 16,482 D
2025-08-19 Alt Aaron E Officer S-Sale D Common Shares 34,455 148.61 5.12M 44,438 D
2025-08-15 WEITZMAN DEBORAH Officer F-InKind D Common Shares 24,128 150.22 3.62M 74,795 D
2025-08-15 Snow Ola M Officer A-Award A Common Shares 6,417 0.00 61,768 D
2025-08-15 Scherer Mary C. Officer F-InKind D Common Shares 2,572 150.22 386.4K 10,322 D
2025-08-15 Mayer Jessica L Officer F-InKind D Common Shares 27,927 150.22 4.20M 86,535 D
2025-08-15 Mason Stephen M Officer F-InKind D Common Shares 30,811 150.22 4.63M 67,660 D
2025-08-15 Hollar Jason M. Officer F-InKind D Common Shares 136,407 150.22 20.49M 343,606 D
2025-08-15 Greene Michelle D. Officer A-Award A Common Shares 3,476 0.00 38,444 D
2025-08-15 Alt Aaron E Officer F-InKind D Common Shares 34,866 150.22 5.24M 78,893 D
2025-08-12 WEITZMAN DEBORAH Officer A-Award A Common Shares 39,100 0.00 88,229 D
2025-08-12 Snow Ola M Officer A-Award A Common Shares 31,813 0.00 55,351 D
2025-08-12 Scherer Mary C. Officer A-Award A Common Shares 3,029 0.00 11,691 D
2025-08-12 Mayer Jessica L Officer A-Award A Common Shares 49,994 0.00 105,104 D
2025-08-12 Mason Stephen M Officer A-Award A Common Shares 54,537 0.00 89,514 D
2025-08-12 Hollar Jason M. Officer A-Award A Common Shares 245,420 0.00 437,235 D
2025-08-12 Greene Michelle D. Officer A-Award A Common Shares 16,362 0.00 34,968 D
2025-08-12 Alt Aaron E Officer A-Award A Common Shares 67,448 0.00 102,396 D
2025-06-30 Snow Ola M Officer F-InKind D Common Shares 3,623 167.18 605.7K 23,538 D
2025-06-30 Mayer Jessica L Officer F-InKind D Common Shares 5,176 167.18 865.3K 55,110 D
2025-06-30 Mason Stephen M Officer F-InKind D Common Shares 5,694 167.18 951.9K 34,977 D
2025-06-30 Hollar Jason M. Officer F-InKind D Common Shares 5,821 167.18 973.2K 191,815 D
2025-03-15 Ramakrishna Sudhakar Director A-Award A Common Shares 1,049 0.00 1,049 D
2025-03-15 Musslewhite Robert W Director A-Award A Common Shares 1,049 0.00 1,049 D
2025-03-07 Ramakrishna Sudhakar Director Common Shares 0 0.00 0 D
2025-03-07 Musslewhite Robert W Director Common Shares 0 0.00 0 D
2025-02-15 Greene Michelle D. Officer F-InKind D Common Shares 636 126.21 80.3K 18,606 D
2025-02-15 Alt Aaron E Officer F-InKind D Common Shares 1,919 126.21 242.2K 34,948 D
2024-12-02 WEITZMAN DEBORAH Officer F-InKind D Common Shares 632 122.24 77.3K 49,129 D
2024-12-02 Snow Ola M Officer F-InKind D Common Shares 355 122.24 43.4K 27,161 D
2024-12-02 Scherer Mary C. Officer F-InKind D Common Shares 90 122.24 11.0K 8,662 D
2024-12-02 Mayer Jessica L Officer F-InKind D Common Shares 676 122.24 82.6K 60,286 D
2024-11-15 Mayer Jessica L Officer F-InKind D Common Shares 5,186 121.29 629.0K 70,785 D
2024-11-14 Scherer Mary C. Officer S-Sale D Common Shares 3,504 123.55 432.9K 8,752 D
2024-11-06 MUNDKUR CHRISTINE Director A-Award A Common Shares 1,730 0.00 6,469 D
2024-11-06 Killefer Nancy Director A-Award A Common Shares 1,730 0.00 26,557 D
2024-11-06 KENNY GREGORY B Director A-Award A Common Shares 2,812 0.00 62,492 D
2024-11-06 JOHRI AKHIL Director A-Award A Common Shares 1,730 0.00 21,801 D
2024-11-06 Hall Patricia Hemingway Director A-Award A Common Shares 1,730 0.00 31,197 D
2024-11-06 Evans David C Director A-Award A Common Shares 1,730 0.00 14,306 D
2024-11-06 Edison Sheri H. Director A-Award A Common Shares 1,730 0.00 13,781 D
2024-11-06 Brennan Michelle Director A-Award A Common Shares 1,730 0.00 7,019 D
2024-11-06 Azelby Robert Director A-Award A Common Shares 1,730 0.00 3,018 D
2024-08-21 Mayer Jessica L Officer S-Sale D Common Shares 16,573 109.39 1.81M 75,971
2024-08-19 Snow Ola M Officer M-Exempt D Employee Stock Option (right to buy) 5,980 83.19 497.5K 0
2024-08-19 Mason Stephen M Officer M-Exempt A Common Shares 8,971 83.19 746.3K 87,669
2024-08-19 Hollar Jason M. Officer S-Sale D Common Shares 46,455 109.02 5.06M 197,636
2024-08-19 Greene Michelle D. Officer S-Sale D Common Shares 4,000 108.85 435.4K 19,242
2024-08-19 Alt Aaron E Officer S-Sale D Common Shares 2,323 108.91 253.0K 36,867
2024-08-16 WEITZMAN DEBORAH Officer F-InKind D Common Shares 2,341 107.91 252.6K 49,761
2024-08-16 Snow Ola M Officer G-Gift D Common Shares 943 0.00 44,496
2024-08-16 Scherer Mary C. Officer F-InKind D Common Shares 249 107.91 26.9K 12,256
2024-08-16 Mayer Jessica L Officer F-InKind D Common Shares 1,985 107.91 214.2K 92,544
2024-08-16 Mason Stephen M Officer F-InKind D Common Shares 1,985 107.91 214.2K 72,708
2024-08-16 Hollar Jason M. Officer S-Sale D Common Shares 26,716 108.87 2.91M 244,091
2024-08-16 Greene Michelle D. Officer F-InKind D Common Shares 1,493 107.91 161.1K 23,242
2024-08-16 Alt Aaron E Officer F-InKind D Common Shares 2,481 107.91 267.7K 39,190
2024-08-15 WEITZMAN DEBORAH Officer A-Award A Common Shares 13,530 0.00 52,102
2024-08-15 Snow Ola M Officer F-InKind D Common Shares 12,576 106.36 1.34M 41,511
2024-08-15 Scherer Mary C. Officer F-InKind D Common Shares 2,380 106.36 253.1K 10,837
2024-08-15 Mayer Jessica L Officer M-Exempt D Employee Stock Option (right to buy) 5,534 66.43 367.6K 0
2024-08-15 Mason Stephen M Officer A-Award A Common Shares 12,047 0.00 74,693
2024-08-15 Hollar Jason M. Officer F-InKind D Common Shares 30,275 106.36 3.22M 230,494
2024-08-15 Greene Michelle D. Officer F-InKind D Common Shares 2,355 106.36 250.5K 19,916
2024-08-15 Alt Aaron E Officer A-Award A Common Shares 14,271 0.00 41,671
2024-08-13 WEITZMAN DEBORAH Officer A-Award A Common Shares 13,926 0.00 48,490
2024-08-13 Snow Ola M Officer A-Award A Common Shares 29,245 0.00 54,087
2024-08-13 Scherer Mary C. Officer A-Award A Common Shares 2,785 0.00 13,217
2024-08-13 Mayer Jessica L Officer A-Award A Common Shares 41,780 0.00 111,068
2024-08-13 Mason Stephen M Officer A-Award A Common Shares 45,958 0.00 83,313
2024-08-13 Hollar Jason M. Officer A-Award A Common Shares 45,958 0.00 260,769
2024-08-13 Greene Michelle D. Officer A-Award A Common Shares 2,785 0.00 22,271
2024-03-15 Greene Michelle D. Officer F-InKind D Common Shares 664 109.93 73.0K 19,486
2024-03-15 Azelby Robert Director A-Award A Common Shares 1,288 0.00 1,288
2024-03-01 Azelby Robert Director 0 0.00 0
2024-02-15 Greene Michelle D. Officer F-InKind D Common Shares 664 103.55 68.8K 20,150
2024-02-15 Alt Aaron E Officer F-InKind D Common Shares 1,919 103.55 198.7K 27,400
2023-12-01 WEITZMAN DEBORAH Officer F-InKind D Common Shares 638 107.08 68.3K 34,564
2023-12-01 Snow Ola M Officer F-InKind D Common Shares 382 107.08 40.9K 24,842
2023-12-01 Scherer Mary C. Officer F-InKind D Common Shares 217 107.08 23.2K 10,432
2023-11-27 WEITZMAN DEBORAH Officer M-Exempt D Employee Stock Option (right to buy) 15,373 66.43 1.02M 0
2023-11-15 Mayer Jessica L Officer F-InKind D Common Shares 5,185 102.90 533.5K 79,680
2023-11-15 MUNDKUR CHRISTINE Director A-Award A Common Shares 1,965 0.00 4,739
2023-11-15 Killefer Nancy Director A-Award A Common Shares 1,965 0.00 24,827
2023-11-15 KENNY GREGORY B Director A-Award A Common Shares 3,193 0.00 59,680
2023-11-15 JOHRI AKHIL Director A-Award A Common Shares 1,965 0.00 20,071
2023-11-15 Hall Patricia Hemingway Director A-Award A Common Shares 1,965 0.00 29,467
2023-11-15 Evans David C Director A-Award A Common Shares 1,965 0.00 12,576
2023-11-15 Edison Sheri H. Director A-Award A Common Shares 1,965 0.00 12,051
2023-11-15 Chandrasekaran Sujatha Director A-Award A Common Shares 1,965 0.00 4,739
2023-11-15 Brennan Michelle Director A-Award A Common Shares 1,965 0.00 5,289
2023-11-15 Barg Steven Director A-Award A Common Shares 1,965 0.00 4,739
2023-08-28 WEITZMAN DEBORAH Officer S-Sale D Common Shares 6,712 89.81 602.8K 44,202
2023-08-18 Scherer Mary C. Officer S-Sale D Common Shares 20,695 86.27 1.79M 10,649
2023-08-17 Snow Ola M Officer M-Exempt D Employee Stock Option (right to buy) 3,907 71.43 279.1K 0
2023-08-17 Mayer Jessica L Officer S-Sale D Common Shares 10,668 87.68 935.4K 84,865
2023-08-17 Mason Stephen M Officer S-Sale D Common Shares 7,977 88.42 705.3K 37,355
2023-08-17 Greene Michelle D. Officer S-Sale D Common Shares 2,000 86.79 173.6K 20,814
2023-08-16 WEITZMAN DEBORAH Officer A-Award A Common Shares 15,487 0.00 44,202
2023-08-16 Snow Ola M Officer A-Award A Common Shares 9,956 0.00 48,179
2023-08-16 Scherer Mary C. Officer A-Award A Common Shares 1,659 0.00 19,884
2023-08-16 Mayer Jessica L Officer M-Exempt A Common Shares 973 84.27 82.0K 125,678
2023-08-16 Mason Stephen M Officer A-Award A Common Shares 13,274 0.00 74,855
2023-08-16 Hollar Jason M. Officer A-Award A Common Shares 53,097 0.00 214,811
2023-08-16 Greene Michelle D. Officer A-Award A Common Shares 10,398 0.00 22,814
2023-08-16 Alt Aaron E Officer A-Award A Common Shares 16,593 0.00 29,319
2023-08-15 WEITZMAN DEBORAH Officer F-InKind D Common Shares 10,966 92.99 1.02M 28,715
2023-08-15 Snow Ola M Officer F-InKind D Common Shares 15,031 92.99 1.40M 38,223
2023-08-15 Scherer Mary C. Officer F-InKind D Common Shares 2,852 92.99 265.2K 18,225
2023-08-15 Mayer Jessica L Officer F-InKind D Common Shares 20,010 92.99 1.86M 110,289
2023-08-15 Mason Stephen M Officer F-InKind D Common Shares 25,701 92.99 2.39M 61,581
2023-08-15 Hollar Jason M. Officer F-InKind D Common Shares 20,771 92.99 1.93M 161,714
2023-08-15 Greene Michelle D. Officer F-InKind D Common Shares 1,239 92.99 115.2K 12,416
2023-08-07 WEITZMAN DEBORAH Officer A-Award A Common Shares 12,760 0.00 39,681
2023-08-07 Snow Ola M Officer A-Award A Common Shares 22,969 0.00 53,254
2023-08-07 Scherer Mary C. Officer A-Award A Common Shares 2,552 0.00 21,077
2023-08-07 Mayer Jessica L Officer A-Award A Common Shares 28,329 0.00 130,104
2023-08-07 Mason Stephen M Officer A-Award A Common Shares 38,282 0.00 87,282
2023-08-07 Hollar Jason M. Officer A-Award A Common Shares 38,282 0.00 182,485
2023-06-30 DOWNEY BRUCE Director 0 0.00 0
2023-05-15 Hollar Jason M. Officer F-InKind D Common Shares 3,037 84.77 257.4K 144,203
2023-03-15 Mayer Jessica L Officer F-InKind D Common Shares 1,336 70.72 94.5K 101,775
2023-03-15 Greene Michelle D. Officer F-InKind D Common Shares 669 70.72 47.3K 13,655
2023-02-15 Alt Aaron E Officer A-Award A Common Shares 12,726 0.00 12,726
2023-02-10 Alt Aaron E Officer 0 0.00 0
2022-12-01 WEITZMAN DEBORAH Officer F-InKind D Common Shares 380 80.17 30.5K 26,921
2022-12-01 Snow Ola M Officer F-InKind D Common Shares 596 80.17 47.8K 29,961
2022-11-15 Mayer Jessica L Officer F-InKind D Common Shares 5,185 75.21 390.0K 120,827
2022-11-15 Brennan Michelle Director P-Purchase A Common Shares 200 74.72 14.9K 3,324
2022-11-14 Brennan Michelle Director P-Purchase A Common Shares 200 76.30 15.3K 3,124
2022-11-10 Brennan Michelle Director P-Purchase A Common Shares 150 79.74 12.0K 2,924
2022-11-09 MUNDKUR CHRISTINE Director A-Award A Common Shares 2,308 0.00 2,774
2022-11-09 Killefer Nancy Director A-Award A Common Shares 2,308 0.00 22,862
2022-11-09 KENNY GREGORY B Director A-Award A Common Shares 3,867 0.00 56,487
2022-11-09 JOHRI AKHIL Director A-Award A Common Shares 2,308 0.00 18,106
2022-11-09 Hall Patricia Hemingway Director A-Award A Common Shares 2,308 0.00 27,502
2022-11-09 Evans David C Director A-Award A Common Shares 2,308 0.00 10,611
2022-11-09 Edison Sheri H. Director A-Award A Common Shares 2,308 0.00 10,086
2022-11-09 DOWNEY BRUCE Director A-Award A Common Shares 2,308 0.00 53,929
2022-11-09 Chandrasekaran Sujatha Director A-Award A Common Shares 2,308 0.00 2,774
2022-11-09 COX CARRIE SMITH Director A-Award A Common Shares 2,308 0.00 41,631
2022-11-09 Brennan Michelle Director A-Award A Common Shares 2,308 0.00 2,774
2022-11-09 Barg Steven Director A-Award A Common Shares 2,308 0.00 2,774
2022-11-07 Snow Ola M Officer G-Gift D Common Shares 630 0.00 30,557
2022-11-07 Mason Stephen M Officer M-Exempt A Common Shares 12,176 66.43 808.9K 110,216
2022-10-18 SCARBOROUGH DEAN A Director A-Award A Phantom Stock 406 70.66 28.7K 6,659
2022-09-15 MUNDKUR CHRISTINE Director A-Award A Common Shares 466 0.00 466
2022-09-15 Chandrasekaran Sujatha Director A-Award A Common Shares 466 0.00 466
2022-09-15 Brennan Michelle Director A-Award A Common Shares 466 0.00 466
2022-09-06 MUNDKUR CHRISTINE Director 0 0.00 0
2022-09-06 Chandrasekaran Sujatha Director 0 0.00 0
2022-09-06 Brennan Michelle Director 0 0.00 0
2022-08-26 Greene Michelle D. Officer D Common Shares 0 0.00 14,324
2022-08-15 Snow Ola M Officer F-InKind D Common Shares 12,803 69.32 887.5K 50,777
2022-08-15 Rice Brian S Officer F-InKind D Common Shares 9,850 69.32 682.8K 37,850
2022-08-15 Mayer Jessica L Officer M-Exempt A Common Shares 442 39.81 17.6K 126,351
2022-08-15 Mason Stephen M Officer A-Award A Common Shares 17,150 0.00 115,931
2022-08-15 Kaufmann Michael C Officer M-Exempt D Employee Stock Option (right to buy) 96,291 0.00 0
2022-08-15 Hollar Jason M. Officer F-InKind D Common Shares 8,206 69.32 568.8K 147,240
2022-08-15 Holcomb Michele Officer F-InKind D Common Shares 9,687 69.32 671.5K 44,491
2022-08-15 English Patricia M Officer A-Award A Common Shares 2,144 0.00 10,313
2022-08-15 CRAWFORD VICTOR L. Officer A-Award A Common Shares 17,150 0.00 135,651
2022-08-09 Snow Ola M Officer A-Award A Common Shares 16,607 0.00 53,576
2022-08-09 Rice Brian S Officer A-Award A Common Shares 13,286 0.00 47,700
2022-08-09 Mayer Jessica L Officer A-Award A Common Shares 23,250 0.00 128,061
2022-08-09 Mason Stephen M Officer A-Award A Common Shares 29,893 0.00 98,781
2022-08-09 Kaufmann Michael C Officer A-Award A Common Shares 132,857 0.00 672,988
2022-08-09 Hollar Jason M. Officer A-Award A Common Shares 18,999 0.00 71,124
2022-08-09 Holcomb Michele Officer A-Award A Common Shares 13,286 0.00 54,178
2022-08-09 CRAWFORD VICTOR L. Officer A-Award A Common Shares 36,536 0.00 118,501

Executive team

Top executives
EBIT / Employee
40.1K
Shares Outstanding
235.32M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Jason M. Hollar Chief Executive Officer 1.49M 13.43M 3.55M 500.7K 18.98M 70.78%
2 2025 Aaron E. Alt Chief Financial Officer 871.2K 3.98M 1.30M 57.8K 6.21M 64.05%
3 2025 Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment 741.9K 3.77M 964.5K 30.2K 5.51M 68.47%
4 2025 Jessica L. Mayer Chief Legal and Compliance Officer 716.9K 3.20M 975.0K 30.5K 4.93M 65.03%
5 2025 Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment 741.9K 3.36M 593.5K 51.7K 4.75M 70.77%
6 2024 Jason M. Hollar Chief Executive Officer 1.43M 20.64M 3.11M 464.0K 25.65M 80.47%
7 2024 Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment 721.0K 5.97M 627.3K 16.2K 7.34M 81.40%
8 2024 Aaron E. Alt Chief Financial Officer 846.0K 4.82M 1.15M 18.7K 6.84M 70.50%
9 2024 Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment 709.2K 3.60M 758.8K 21.9K 5.09M 70.72%
10 2024 Jessica L. Mayer Chief Legal and Compliance Officer 696.0K 3.08M 863.1K 13.8K 4.66M 66.23%
11 2023 Jason M. Hollar Chief Executive Officer 1.25M 14.83M 2.38M 328.3K 18.79M 78.93%
12 2023 Jason M. Hollar Chief Executive Officer and Former Chief Financial Officer 1.25M 14.83M 2.38M 318.3K 18.78M 78.98%
13 2023 Aaron E. Alt Chief Financial Officer 375.2K 1.00M 3.82M 544.8K 265.0K 6.00M 63.59%
14 2023 Victor L. Crawford Former Chief Executive Officer, Pharmaceutical Segment 280.7K 3.18M 1.30M 4.77M 66.76%
15 2023 Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment 696.0K 3.18M 522.0K 20.7K 4.42M 71.99%
16 2023 Stephen M. Mason Chief Executive Officer, Medical Segment 696.0K 3.18M 522.0K 13.2K 4.42M 72.12%
17 2023 Jessica L. Mayer Chief Legal and Compliance Officer 666.9K 2.92M 800.3K 13.8K 4.40M 66.34%
18 2023 Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment 606.1K 2.67M 774.0K 19.0K 4.07M 65.64%
19 2023 Deborah L. Weitzman Chief Executive Officer, Pharmaceutical Segment 606.1K 2.67M 774.0K 17.8K 4.07M 65.66%
20 2023 Michael C. Kaufmann Former Chief Executive Officer 233.0K 3.30M 3.53M 0.00%
21 2023 Patricia M. English Former Interim Chief Financial Officer 291.5K 811.4K 146.7K 13.2K 1.26M 64.26%
22 2022 Michael C. Kaufmann Chief Executive Officer 1.34M 11.05M 805.1K 265.6K 13.46M 82.08%
23 2022 Michael C. Kaufmann Former Chief Executive Officer 1.34M 11.05M 805.1K 265.6K 13.46M 82.08%
24 2022 Jessica L. Mayer Chief Legal and Compliance Officer 616.8K 4.26M 244.2K 12.4K 5.14M 82.99%
25 2022 Jason M. Hollar Chief Executive Officer and Former Chief Financial Officer 729.2K 2.76M 320.9K 69.8K 3.88M 71.16%
26 2022 Jason M. Hollar Chief Executive Officer 729.2K 2.76M 320.9K 69.8K 3.88M 71.16%
27 2022 Jason M. Hollar Chief Financial Officer 729.2K 2.76M 320.9K 69.8K 3.88M 71.16%
28 2022 Victor L. Crawford Former Chief Executive Officer, Pharmaceutical Segment 741.3K 2.76M 296.5K 12.2K 3.81M 72.46%
29 2022 Victor L. Crawford Chief Executive Officer - Pharmaceutical Segment 741.3K 2.76M 296.5K 12.2K 3.81M 72.46%
30 2022 Stephen M. Mason Chief Executive Officer, Medical Segment 666.8K 2.76M 166.7K 15.4K 3.61M 76.50%
31 2022 Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment 666.8K 2.76M 166.7K 15.4K 3.61M 76.50%
32 2022 Stephen M. Mason Chief Executive Officer - Medical Segment 666.8K 2.76M 166.7K 15.4K 3.61M 76.50%
33 2021 Michael C. Kaufmann Former Chief Executive Officer 1.30M 10.20M 780.0K 204.5K 12.48M 81.70%
34 2021 Michael C. Kaufmann Chief Executive Officer 1.30M 10.20M 780.0K 204.5K 12.48M 81.70%
35 2021 Victor L. Crawford Chief Executive Officer - Pharmaceutical Segment 725.0K 2.80M 652.5K 35.9K 4.22M 66.49%
36 2021 Victor L. Crawford Former Chief Executive Officer, Pharmaceutical Segment 725.0K 2.80M 652.5K 35.9K 4.22M 66.49%
37 2021 Jason M. Hollar Chief Financial Officer 700.0K 2.55M 630.0K 71.4K 3.95M 64.53%
38 2021 Jason M. Hollar Chief Executive Officer and Former Chief Financial Officer 700.0K 2.55M 630.0K 71.4K 3.95M 64.53%
39 2021 Stephen M. Mason Chief Executive Officer - Medical Segment 625.0K 2.55M 562.5K 17.3K 3.75M 67.91%
40 2021 Stephen M. Mason Chief Executive Officer, Medical Segment 625.0K 2.55M 562.5K 17.3K 3.75M 67.91%
41 2021 Jessica L. Mayer Chief Legal and Compliance Officer 575.0K 1.89M 465.8K 11.8K 2.94M 64.19%
42 2020 Michael C. Kaufmann Chief Executive Officer 1.29M 10.24M 2.55M 143.0K 14.22M 72.03%
43 2020 Victor L. Crawford Chief Executive Officer - Pharmaceutical Segment 721.7K 2.82M 909.3K 14.3K 4.46M 63.12%
44 2020 Jason M. Hollar Chief Financial Officer 124.3K 1.55M 2.07M 149.2K 213.1K 4.10M 50.38%
45 2020 Stephen M. Mason Chief Executive Officer - Medical Segment 511.7K 2.30M 586.3K 21.4K 3.42M 67.30%
46 2020 Jessica L. Mayer Chief Legal and Compliance Officer 547.3K 1.79M 559.1K 15.9K 2.91M 61.49%
47 2020 David C. Evans Former interim Chief Financial Officer 2.18M 26.9K 2.21M 0.00%
48 2020 Jorge M. Gomez Former Chief Financial Officer 65.6K 3.0K 68.5K 0.00%
49 2019 Michael C. Kaufmann Chief Executive Officer 1.19M 12.11M 2.13M 140.6K 15.57M 77.78%
50 2019 Victor L. Crawford Chief Executive Officer - Pharmaceutical Segment 443.0K 2.50M 3.10M 502.4K 184.7K 6.73M 46.03%
51 2019 Jon L. Giacomin Former Chief Executive Officer - Medical Segment 805.3K 3.04M 26.4K 3.87M 78.50%
52 2019 Craig S. Morford Former Chief Legal and Compliance Officer 463.9K 2.28M 425.8K 19.5K 3.19M 71.47%
53 2019 Jorge M. Gomez Former Chief Financial Officer 593.3K 2.53M 26.8K 3.15M 80.32%
54 2019 Jessica L. Mayer Chief Legal and Compliance Officer 429.9K 2.15M 364.9K 19.7K 2.97M 72.55%
55 2018 George S. Barrett Executive Chairman of the Board and Former Chairman and Chief Executive Officer 1.35M 6.33M 3.16M 2.07M 189.7K 13.11M 72.42%
56 2018 Michael C. Kaufmann Chief Executive Officer 955.7K 4.90M 948.7K 1.52M 100.4K 8.42M 69.43%
57 2018 Michael C. Kaufmann Chief Executive Officer and Former Chief Financial Officer 955.7K 4.90M 948.7K 1.52M 100.4K 8.42M 69.43%
58 2018 Jon L. Giacomin Chief Executive Officer - Medical Segment 697.1K 2.90M 948.7K 853.2K 36.1K 5.44M 70.81%
59 2018 Jon L. Giacomin Former Chief Executive Officer - Medical Segment 697.1K 2.90M 948.7K 853.2K 36.1K 5.44M 70.81%
60 2018 Donald M. Casey Jr. Former Chief Executive Officer - Medical Segment 440.4K 1.90M 948.7K 3.1K 3.29M 86.53%
61 2018 Craig S. Morford Former Chief Legal and Compliance Officer 585.2K 1.11M 593.3K 608.8K 31.5K 2.93M 58.17%
62 2018 Craig S. Morford Chief Legal and Compliance Officer 585.2K 1.11M 593.3K 608.8K 31.5K 2.93M 58.17%
63 2018 Patricia B. Morrison Retired Executive Vice President, Customer Support Services and Chief Information Officer 530.4K 1.10M 734.8K 432.8K 30.7K 2.82M 64.81%
64 2018 Jorge M. Gomez Chief Financial Officer 478.1K 1.29M 163.5K 387.4K 37.5K 2.36M 61.76%
65 2018 Jorge M. Gomez Former Chief Financial Officer 478.1K 1.29M 163.5K 387.4K 37.5K 2.36M 61.76%
66 2017 George S. Barrett Executive Chairman of the Board and Former Chairman and Chief Executive Officer 1.32M 6.33M 3.17M 165.5K 10.99M 86.48%
67 2017 George S. Barrett Chairman and Chief Executive Officer 1.32M 6.33M 3.17M 165.5K 10.99M 86.48%
68 2017 Michael C. Kaufmann Chief Executive Officer and Former Chief Financial Officer 746.4K 186.6K 1.95M 997.4K 15.0K 3.89M 75.65%
69 2017 Michael C. Kaufmann Chief Financial Officer 746.4K 186.6K 1.95M 997.4K 15.0K 3.89M 75.65%
70 2017 Michael C. Kaufmann Chief Executive Officer 746.4K 186.6K 1.95M 997.4K 15.0K 3.89M 75.65%
71 2017 Donald M. Casey Jr. Chief Executive Officer-Medical Segment 705.0K 176.3K 1.95M 997.4K 10.8K 3.84M 76.75%
72 2017 Donald M. Casey Jr. Former Chief Executive Officer - Medical Segment 705.0K 176.3K 1.95M 997.4K 10.8K 3.84M 76.75%
73 2017 Jon L. Giacomin Chief Executive Officer - Medical Segment 567.2K 141.8K 1.90M 949.9K 15.0K 3.57M 79.74%
74 2017 Jon L. Giacomin Former Chief Executive Officer - Medical Segment 567.2K 141.8K 1.90M 949.9K 15.0K 3.57M 79.74%
75 2017 Jon L. Giacomin Chief Executive Officer-Pharmaceutical Segment 567.2K 141.8K 1.90M 949.9K 15.0K 3.57M 79.74%
76 2017 Craig S. Morford Chief Legal and Compliance Officer 552.2K 117.3K 1.03M 516.6K 15.0K 2.23M 69.37%
77 2017 Craig S. Morford Former Chief Legal and Compliance Officer 552.2K 117.3K 1.03M 516.6K 15.0K 2.23M 69.37%
78 2016 George S. Barrett Chairman and Chief Executive Officer 1.32M 6.49M 3.33M 2.39M 131.9K 13.66M 71.90%
79 2016 George S. Barrett Executive Chairman of the Board and Former Chairman and Chief Executive Officer 1.32M 6.49M 3.33M 2.39M 131.9K 13.66M 71.90%
80 2016 Michael C. Kaufmann Chief Financial Officer 721.3K 1.58M 826.4K 880.7K 27.3K 4.03M 59.58%
81 2016 Michael C. Kaufmann Chief Executive Officer and Former Chief Financial Officer 721.3K 1.58M 826.4K 880.7K 27.3K 4.03M 59.58%
82 2016 Donald M. Casey Jr. Former Chief Executive Officer — Medical Segment 671.3K 1.51M 806.4K 894.2K 22.8K 3.90M 59.27%
83 2016 Donald M. Casey Jr. Chief Executive Officer — Medical Segment 671.3K 1.51M 806.4K 894.2K 22.8K 3.90M 59.27%
84 2016 Donald M. Casey Jr. Chief Executive Officer—Medical Segment 671.3K 1.51M 806.4K 894.2K 22.8K 3.90M 59.27%
85 2016 Jon L. Giacomin Chief Executive Officer—Pharmaceutical Segment 542.6K 1.40M 701.2K 602.3K 27.8K 3.27M 64.18%
86 2016 Jon L. Giacomin Chief Executive Officer — Medical Segment 542.6K 1.40M 701.2K 602.3K 27.8K 3.27M 64.18%
87 2016 Jon L. Giacomin Chief Executive Officer — Pharmaceutical Segment 542.6K 1.40M 701.2K 602.3K 27.8K 3.27M 64.18%
88 2016 Craig S. Morford Chief Legal and Compliance Officer 531.3K 1.62M 420.7K 576.5K 37.6K 3.19M 64.05%
89 2015 George S. Barrett Chairman and Chief Executive Officer 1.32M 5.98M 3.32M 2.51M 135.2K 13.27M 70.11%
90 2015 Michael C. Kaufmann Chief Financial Officer 688.6K 4.54M 841.0K 1.05M 36.3K 7.16M 75.16%
91 2015 Donald M. Casey Jr. Chief Executive Officer — Medical Segment 650.0K 3.01M 806.0K 618.1K 31.7K 5.11M 74.57%
92 2015 Donald M. Casey Jr. Chief Executive Officer—Medical Segment 650.0K 3.01M 806.0K 618.1K 31.7K 5.11M 74.57%
93 2015 Jeffrey W. Henderson Former Chief Financial Officer 794.0K 1.75M 1.06M 35.7K 3.64M 48.14%
94 2015 Jon L. Giacomin Chief Executive Officer—Pharmaceutical Segment 480.7K 1.24M 629.3K 679.7K 37.2K 3.06M 60.92%
95 2015 Jon L. Giacomin Chief Executive Officer — Pharmaceutical Segment 480.7K 1.24M 629.3K 679.7K 37.2K 3.06M 60.92%
96 2015 Craig S. Morford Chief Legal and Compliance Officer 510.0K 800.0K 400.5K 559.6K 35.5K 2.31M 52.07%
97 2014 George S. Barrett Chairman and Chief Executive Officer 1.31M 5.53M 2.87M 2.60M 132.4K 12.45M 67.47%
98 2014 Jeffrey W. Henderson Chief Financial Officer 756.9K 1.63M 816.5K 1.15M 32.2K 4.39M 55.79%
99 2014 Jeffrey W. Henderson Former Chief Financial Officer 756.9K 1.63M 816.5K 1.15M 32.2K 4.39M 55.79%
100 2014 Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment 647.7K 1.40M 699.9K 1.23M 32.3K 4.01M 52.38%
101 2014 Michael C. Kaufmann Chief Financial Officer 647.7K 1.40M 699.9K 1.23M 32.3K 4.01M 52.38%
102 2014 Donald M. Casey Jr. Chief Executive Officer — Medical Segment 647.7K 1.47M 769.9K 544.1K 28.2K 3.46M 64.74%
103 2014 Craig S. Morford Chief Legal and Compliance Officer 508.5K 799.9K 399.9K 553.0K 32.4K 2.29M 52.31%
104 2013 George S. Barrett Chairman and Chief Executive Officer 1.29M 5.34M 2.70M 2.02M 137.6K 11.47M 69.99%
105 2013 Jeffrey W. Henderson Former Chief Financial Officer 740.0K 1.67M 836.1K 846.2K 29.1K 4.13M 60.85%
106 2013 Jeffrey W. Henderson Chief Financial Officer 740.0K 1.67M 836.1K 846.2K 29.1K 4.13M 60.85%
107 2013 Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment 635.0K 1.51M 784.9K 714.4K 28.9K 3.67M 62.43%
108 2013 Michael C. Kaufmann Chief Financial Officer 635.0K 1.51M 784.9K 714.4K 28.9K 3.67M 62.43%
109 2013 Donald M. Casey Jr. Chief Executive Officer — Medical Segment 635.0K 1.40M 682.5K 525.8K 37.0K 3.28M 63.49%
110 2013 Craig S. Morford Chief Legal and Compliance Officer 500.0K 820.0K 409.5K 453.8K 29.1K 2.21M 55.57%
111 2012 George S. Barrett Chairman and Chief Executive Officer 1.28M 5.14M 2.86M 1.81M 123.2K 11.21M 71.36%
112 2012 Jeffrey W. Henderson Chief Financial Officer 736.8K 1.66M 831.5K 722.8K 22.8K 3.98M 62.73%
113 2012 Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment 629.4K 1.44M 713.7K 628.7K 23.3K 3.44M 62.72%
114 2012 Michael A. Lynch Former Chief Executive Officer — Medical Segment 584.5K 1.46M 713.7K 431.4K 58.8K 3.25M 66.93%
115 2012 Donald M. Casey Jr. Chief Executive Officer — Medical Segment 131.9K 500.0K 1,000.0K 500.1K 118.7K 506.1K 2.76M 54.42%
116 2012 Craig S. Morford Chief Legal and Compliance Officer 496.0K 712.5K 356.2K 405.5K 24.6K 1.99M 53.58%
117 2011 George S. Barrett Chairman and Chief Executive Officer 1.23M 2.52M 4.40M 1.93M 132.0K 10.21M 67.72%
118 2011 George S. Barrett Chairman and Chief Executive Officer 1.23M 2.52M 4.40M 1.93M 132.0K 10.21M 67.72%
119 2011 Jeffrey W. Henderson Chief Financial Officer 716.7K 808.5K 1.41M 816.0K 25.5K 3.78M 58.75%
120 2011 Jeffrey W. Henderson Chief Financial Officer 716.7K 808.5K 1.41M 816.0K 25.5K 3.78M 58.75%
121 2011 Michael C. Kaufmann Chief Executive Officer— Pharmaceutical Segment 596.7K 669.9K 1.17M 804.8K 27.8K 3.27M 56.27%
122 2011 Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment 596.7K 669.9K 1.17M 804.8K 27.8K 3.27M 56.27%
123 2011 Michael A. Lynch Chief Executive Officer— Medical Segment 615.0K 693.0K 1.21M 359.8K 28.2K 2.91M 65.47%
124 2011 Michael A. Lynch Former Chief Executive Officer — Medical Segment 615.0K 693.0K 1.21M 359.8K 28.2K 2.91M 65.47%
125 2011 Craig S. Morford Chief Legal and Compliance Officer 470.9K 354.4K 388.5K 26.0K 1.24M 28.59%
126 2011 Craig S. Morford Chief Legal and Compliance Officer 470.9K 354.4K 388.5K 26.0K 1.24M 28.59%
127 2010 George S. Barrett Chairman and Chief Executive Officer 1.16M 121.9K 4.27M 6.16M 2.80M 194.7K 14.70M 70.93%
128 2010 George S. Barrett Chairman and Chief Executive Officer 1.16M 121.9K 4.27M 6.16M 2.80M 194.7K 14.70M 70.93%
129 2010 R. Kerry Clark Former Chairman and Chief Executive Officer 250.3K 380.6K 8.01M 8.65M 0.00%
130 2010 Jeffrey W. Henderson Chief Financial Officer 700.0K 105.0K 808.5K 2.71M 1.17M 37.1K 5.52M 63.65%
131 2010 Jeffrey W. Henderson Chief Financial Officer 700.0K 105.0K 808.5K 2.71M 1.17M 37.1K 5.52M 63.65%
132 2010 Michael A. Lynch Former Chief Executive Officer — Medical Segment 600.0K 46.4K 693.0K 2.52M 945.0K 36.7K 4.84M 66.34%
133 2010 Michael A. Lynch Chief Executive Officer— Medical Segment 600.0K 46.4K 693.0K 2.52M 945.0K 36.7K 4.84M 66.34%
134 2010 Michael A. Lynch Chief Executive Officer— Medical Segment 600.0K 46.4K 693.0K 2.52M 945.0K 36.7K 4.84M 66.34%
135 2010 Michael C. Kaufmann Chief Executive Officer— Pharmaceutical Segment 567.5K 48.5K 646.8K 2.44M 970.3K 43.6K 4.72M 65.44%
136 2010 Michael C. Kaufmann Chief Executive Officer — Pharmaceutical Segment 567.5K 48.5K 646.8K 2.44M 970.3K 43.6K 4.72M 65.44%
137 2010 Michael C. Kaufmann Chief Executive Officer— Pharmaceutical Segment 567.5K 48.5K 646.8K 2.44M 970.3K 43.6K 4.71M 65.47%
138 2010 Craig S. Morford Chief Legal and Compliance Officer 450.0K 27.0K 354.4K 1.17M 624.4K 39.6K 2.66M 57.18%
139 2010 Craig S. Morford Chief Legal and Compliance Officer 450.0K 27.0K 354.4K 1.17M 624.4K 39.6K 2.66M 57.18%
140 2009 R. Kerry Clark Chairman of the Board and Chief Executive Officer 1.45M 696.0K 4.01M 6.77M 216.6K 13.15M 82.03%
141 2009 R. Kerry Clark Former Chairman and Chief Executive Officer 1.45M 696.0K 3.04M 4.57M 216.6K 9.97M 76.32%
142 2009 George S. Barrett Vice Chairman and Chief Executive Officer—Healthcare Supply Chain Services 975.0K 390.0K 2.26M 1.37M 246.1K 5.25M 69.29%
143 2009 Jeffrey W. Henderson Chief Financial Officer 700.0K 280.0K 1.91M 1.01M 22.0K 3.92M 74.45%
144 2009 Jeffrey W. Henderson Chief Financial Officer 700.0K 280.0K 1.68M 1.09M 22.0K 3.77M 73.45%
145 2009 George S. Barrett Chairman and Chief Executive Officer 975.0K 390.0K 975.0K 1.18M 246.1K 3.76M 57.19%
146 2009 Ivan K. Fong 497.3K 179.0K 1.20M 519.5K 1.09M 3.49M 49.27%
147 2009 David L. Schlotterbeck Vice Chairman and Chief Executive Officer—Clinical and Medical Products 745.0K 642.1K 769.7K 21.9K 2.19M 64.40%
148 2009 Vivek Jain 450.0K 162.0K 907.2K 429.0K 18.3K 1.97M 67.95%
149 2008 R. Kerry Clark Chairman of the Board and Chief Executive Officer 1.44M 691.8K 9.81M 246.8K 12.19M 0.00%
150 2008 R. Kerry Clark Former Chairman and Chief Executive Officer 1.44M 691.8K 2.94M 4.41M 246.8K 9.73M 75.55%
151 2008 George S. Barrett Chairman and Chief Executive Officer 412.9K 706.5K 5.33M 3.10M 183.9K 9.73M 86.60%
152 2008 George S. Barrett Vice Chairman and Chief Executive Officer—Healthcare Supply Chain Services 412.9K 706.5K 963.3K 386.6K 183.9K 2.65M 50.88%
153 2008 David L. Schlotterbeck Vice Chairman and Chief Executive Officer—Clinical and Medical Products 741.5K 556.1K 315.4K 581.1K 27.9K 2.23M 40.11%
154 2007 R. Kerry Clark Chairman of the Board and Chief Executive Officer 1.40M 1.12M 8.40M 300.4K 12.68M 0.00%
155 2007 R. Kerry Clark President and Chief Executive Officer 1.40M 1.12M 2.58M 1.46M 300.4K 10.82M 23.79%
156 2007 Robert D. Walter Executive Chairman of the Board 900.0K 577.5K 1.55M 393.3K 8.53M 6.77%
157 2007 Mark W. Parrish Chief Executive Officer — Healthcare Supply Chain Services 620.5K 877.7K 689.9K 37.7K 3.41M 25.76%
158 2007 David L. Schlotterbeck Vice Chairman and Chief Executive Officer—Clinical and Medical Products 725.0K 33.2K 1.42M 961.0K 103.0K 3.25M 44.59%
159 2007 David L. Schlotterbeck Chief Executive Officer — Clinical and Medical Products 725.0K 33.2K 961.0K 103.0K 3.25M 1.02%
160 2007 Jeffrey W. Henderson Chief Financial Officer 653.4K 757.0K 788.2K 32.4K 3.21M 23.57%
161 2006 R. Kerry Clark President and Chief Executive Officer 296.2K 460.3K 7.73M 665.0K 17.2K 8.50M 98.72%
162 2006 Robert D. Walter Executive Chairman of the Board and Former Chief Executive Officer 1.07M 2.91M 3.19M 1.24M 102.2K 7.27M 61.00%
163 2006 Ronald K. Labrum Chairman and Chief Executive Officer—Healthcare Supply Chain Services 632.5K 671.7K 1.46M 168.6K 2.85M 5.62M 29.00%
164 2006 George L. Fotiades Former President and Chief Operating Officer 701.9K 400.0K 3.88M 4.98M 0.00%
165 2006 David L. Schlotterbeck Chief Executive Officer—Pharmaceutical and Medical Products 578.7K 778.1K 2.34M 3.70M 0.00%
166 2006 Jeffrey W. Henderson Chief Financial Officer 552.1K 742.5K 50.8K 1.35M 0.00%
167 2005 Robert D. Walter Executive Chairman of the Board and Former Chief Executive Officer 1.07M 1.59M 705.0K 32.1K 2.68M 26.26%
168 2005 Robert D. Walter Chairman and Chief Executive Officer 1.07M 1.59M 32.1K 2.68M 0.00%
169 2005 Jeffrey W. Henderson Chief Financial Officer 114.2K 323.3K 1.14M 108.1K 4.5K 1.58M 78.86%
170 2005 George L. Fotiades President and Chief Operating Officer 751.1K 683.8K 36.1K 1.47M 0.00%
171 2005 George L. Fotiades Former President and Chief Operating Officer 751.1K 683.8K 36.1K 1.47M 0.00%
172 2005 Ronald K. Labrum Chairman and Chief Executive Officer—Healthcare Supply Chain Services 545.0K 392.9K 308.1K 105.0K 30.3K 1.28M 32.37%
173 2005 Ronald K. Labrum Chairman and Chief Executive Officer — Healthcare Supply Chain Services 545.0K 392.9K 308.1K 30.3K 1.28M 24.14%
174 2005 Anthony J. Rucci Executive Vice President and President of Strategic Corporate Resources 467.6K 303.4K 440.1K 29.2K 1.24M 35.48%
175 2005 David L. Schlotterbeck Chief Executive Officer—Pharmaceutical and Medical Products 560.0K 539.3K 244.6K 22.2K 1.12M 21.81%
176 2004 Robert D. Walter Chairman and Chief Executive Officer 1.04M 12.3K 1.05M 0.00%
177 2004 Robert D. Walter Executive Chairman of the Board and Former Chief Executive Officer 1.04M 507.1K 12.3K 1.05M 48.30%
178 2004 Ronald K. Labrum Chairman and Chief Executive Officer — Healthcare Supply Chain Services 490.4K 306.9K 7.3K 804.6K 38.14%
179 2004 Ronald K. Labrum Chairman and Chief Executive Officer—Healthcare Supply Chain Services 490.4K 306.9K 85.3K 7.3K 804.6K 48.74%
180 2004 George L. Fotiades Former President and Chief Operating Officer 627.7K 225.0K 11.3K 639.0K 35.21%
181 2004 George L. Fotiades President and Chief Operating Officer 627.7K 11.3K 639.0K 0.00%
182 2004 Anthony J. Rucci Executive Vice President and President of Strategic Corporate Resources 445.8K 8.9K 454.7K 0.00%
183 2003 Robert D. Walter Chairman and Chief Executive Officer 1.02M 2.11M 36.5K 3.16M 0.00%
184 2003 George L. Fotiades President and Chief Operating Officer 532.1K 387.4K 36.0K 955.5K 0.00%
185 2003 Anthony J. Rucci Executive Vice President and President of Strategic Corporate Resources 433.7K 279.1K 34.1K 746.8K 0.00%
186 2003 Ronald K. Labrum Chairman and Chief Executive Officer — Healthcare Supply Chain Services 446.7K 247.6K 29.5K 723.8K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-09-16 DEFA14A
2025-09-16 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-04-30 8-K
2026-04-30 10-Q
2026-04-29 SC 13G
2026-04-29 SC 13G
2026-04-17 4
2026-03-26 SC 13G/A
2026-03-23 8-K
2026-03-05 8-K
2026-03-03 4
2026-02-18 4

Executive team

NameTitleCompensationGender
Jason Hollar Chief Executive Officer & Director 6M male
Aaron E. Alt Chief Financial Officer 2M male
Deborah L. Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment 2M female
Jessica L. Mayer Chief Legal & Compliance Officer 2M female
Stephen Mason Chief Executive Officer of GMPD segment 1M male
Patricia English Senior Vice President 451.3K female
Valerie Christine Pitteroff Chief Human Resources Officer female
Ben Brinker President of Global Operations & Supply Chain male
Craig Cowman President of Biopharma Solutions & Strategic Sourcing male
Mary C. Scherer Senior Vice President & Chief Accounting Officer female
Matt Sims Vice President of Investor Relations
Val Pitteroff Chief Human Resources Officer female
ESG Rating
B-
MEDICAL - DISTRIBUTION
2016
E (Environmental)
62.3 / 73.2
Company / Sector avg.
S (Social)
55.5 / 63.7
Company / Sector avg.
G (Governance)
68.0 / 59.8
Company / Sector avg.
ESG Total
61.9 / 65.6
Company / Sector avg.
ESG Score History MEDICAL - DISTRIBUTION
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
Transaction Date Disclosed Senator State Owner Type Amount Link
2020-04-07 2020-05-01 Kelly Loeffler GA Spouse Sale (Full) $100,001 - $250,000
2020-04-07 2020-05-01 Kelly Loeffler GA Spouse Purchase $1,001 - $15,000
2020-03-20 2020-05-01 Kelly Loeffler GA Spouse Purchase $100,001 - $250,000
House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2025-10-24 2025-10-29 Marjorie Taylor Greene GA14 Purchase $1,001 - $15,000
2025-09-05 2025-10-03 Ro Khanna CA17 Sale $1,001 - $15,000
2025-05-14 2025-05-20 Marjorie Taylor Greene GA14 Purchase $1,001 - $15,000
2025-05-05 2025-05-07 Marjorie Taylor Greene GA14 Purchase $1,001 - $15,000
2025-04-08 2025-05-08 Rob Bresnahan PA08 Purchase $1,001 - $15,000
2025-03-17 2025-03-20 Marjorie Taylor Greene GA14 Purchase $1,001 - $15,000
2025-01-21 2025-01-28 Marjorie Taylor Greene GA14 Purchase $1,001 - $15,000
2024-09-20 2024-09-23 Marjorie Taylor Greene GA14 Purchase $1,001 - $15,000
2024-09-04 2024-09-06 John James MI10 Sale (Full) $1,001 - $15,000
2024-06-03 2024-09-02 John James MI10 Purchase $1,001 - $15,000
2024-05-02 2024-09-02 John James MI10 Purchase $1,001 - $15,000
2024-02-13 2024-03-06 Ro Khanna CA17 Sale $1,001 - $15,000
2024-01-12 2024-02-15 Jonathan Jackson IL01 Joint Purchase $50,001 - $100,000
2024-01-10 2024-02-05 Ro Khanna CA17 Purchase $1,001 - $15,000
2023-09-06 2023-10-06 Ro Khanna CA17 Spouse Sale $1,001 - $15,000
2023-06-29 2023-07-11 Ro Khanna CA17 Spouse Purchase $1,001 - $15,000
2023-02-10 2023-03-08 Ro Khanna CA17 Spouse Sale $1,001 - $15,000
2023-01-11 2023-02-07 Ro Khanna CA17 Sale $1,001 - $15,000
2022-12-06 2023-01-03 Ro Khanna CA17 Spouse Purchase $1,001 - $15,000
2022-08-03 2022-09-14 Kathy Manning NC06 Joint Sale (Full) $1,001 - $15,000
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits